Literature DB >> 17594520

ARC contributes to the inhibitory effect of preconditioning on cardiomyocyte apoptosis.

Yu Zhen Li1, Xiu Hua Liu, Xiao Mei Zhu, Li Rong Cai.   

Abstract

UNLABELLED: Inhibition of cardiomyocyte apoptosis plays a key role in preconditioning-triggered cardioprotection. However, the molecular mechanism(s) by which preconditioning inhibits apoptosis is not fully understood. Apoptosis repressor with caspase recruitment domain (ARC) possesses the ability to block hypoxia-induced cardiomyocyte apoptosis. We tested whether ARC contributes to the inhibitory effect of preconditioning on cardiomyocyte apoptosis. Cardiomyocytes from 1-day-old male Sprague-Dawley rats were preconditioned by exposing to 10 min of hypoxia, followed by 30 min of reoxygenation. Then, the preconditioned and non-preconditioned cardiomyocytes were exposed to 90 min of hypoxia followed by 120 min of reoxygenation. The results showed that preconditioning inhibited cell death induced by hypoxia and reoxygenation. Hypoxia and reoxygenation could induce a decrease of ARC protein levels. Intriguingly, preconditioning could maintain ARC protein levels. Inhibition of endogenous ARC expression by ARC antisense oligonucleotides reduced the inhibitory effect of preconditioning on apoptosis. Furthermore, preconditioning-induced suppression of the release of mitochondrial cytochrome c to cytosol and caspase-3 activation could be abolished by the inhibition of endogenous ARC expression using ARC antisense oligonucleotides.
CONCLUSION: These data indicate that ARC participates in preconditioning-triggered cardioprotection by interfering with cytochrome c release and caspase-3 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594520     DOI: 10.1007/s10495-007-0094-4

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  5 in total

1.  Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

Authors:  Bing Z Carter; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Deborah A Thomas; Farhad Ravandi; Hagop M Kantarjian; Erich Koller; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2010-11-01       Impact factor: 22.113

2.  Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.

Authors:  P Y Mak; D H Mak; H Mu; Y Shi; P Ruvolo; V Ruvolo; R Jacamo; J K Burks; W Wei; X Huang; S M Kornblau; M Andreeff; B Z Carter
Journal:  Apoptosis       Date:  2014-04       Impact factor: 4.677

3.  Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K-Akt pathways.

Authors:  Shiv S Prasad; Marsha Russell; Margeryta Nowakowska
Journal:  J Mol Neurosci       Date:  2010-10-15       Impact factor: 3.444

4.  Apoptosis repressor with caspase recruitment domain enhances survival and promotes osteogenic differentiation of human osteoblast cells under Zoledronate treatment.

Authors:  Longwei Hu; Jing Han; Xi Yang; Yang Wang; Hongya Pan; Liqun Xu
Journal:  Mol Med Rep       Date:  2016-08-24       Impact factor: 2.952

Review 5.  Role of apoptosis repressor with caspase recruitment domain (ARC) in cancer.

Authors:  Zhongjie Yu; Qi Li; Yi An; Xiatian Chen; Ziqian Liu; Zhe Li; Jinning Gao; Lynn Htet Htet Aung; Peifeng Li
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.